Strategic Initiative
Slingshot members are tracking this corporate initiative:
Sarepta (SRPT) Announces $300 MM Offering of Common Stock at $59.75 Per Share to Fund Further Clinical Trials, Commercialization, Manufacturing, Business Development, and Potential Licensing or Acquisition of Complementary Products
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Sep 22, 2016 Projected Implementation: Q3, 2016 Relevance Tracked Until: Q3, 2017
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Public Offering Of Common Stock, Clinical Trials, Commercialization, Manufacturing, Business Development, Licensing, Acquisition, Corporate Purposes
